Roberto De Ponti
InvestorManaging Director at 3B Future Health Fund · Senior Advisor at Claris Ventures · Board director at FORE US Bio · Board director at OncoResponse
Monte-Carlo, Monaco, Monaco
About
Senior Advisor and pharmacist / EU Qualified Person with deep experience in pharmaceutical development, corporate ventures and strategic investments in oncology and rare diseases.
Board director at FORE US Bio
Intro paths
→
In turn, Roberto can intro founders to FORE US Bio's investors below.
Board director at OncoResponse
Intro paths
→
In turn, Roberto can intro founders to OncoResponse's investors below.
OncoResponse's investors · 10
3B Future Health FundMonaco · $12M checks · since 2025ARCH Venture PartnersChicago · $50K – $250M checks · since 2021Bering CapitalSan Francisco · since 2023Canaan PartnersStamford · $500K – $20M checks · since 2025GreatPoint VenturesSan Francisco · $250K – $20M checksIntervestChevy Chase · since 2023Qatar Investment AuthorityDohaRiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2025Takeda VenturesCambridge · $1M – $5M checks · since 2023Yonjin Venture LLCCambridge
Experience
- 3B Future Health Fund I & IIGeneral Partnercurrent2022 — presentMonaco, Principato di Monaco
- Geneos TherapeuticsBoard Observercurrent2023 — present
- Domain TherapeuticsBoard Membercurrent2022 — present
- Epsilogen LtdBoard Observercurrent2022 — present
- Roca TherapeuticsBoard Membercurrent2021 — present
- Claris Ventures SGR SpAAdvisorcurrent2020 — present
- OncoResponse Inc.Board Membercurrent2016 — present
- iOncturaBoard Observer2020 — 2024
- Fore BiotherapeuticsBoard Member2018 — 2023
- GreenBone Ortho S.p.A.Board Member2020 — 2022
- Helsinn GroupHead, Corporate New Ventures and Strategic Investments2016 — 2021
- Helsinn GroupHead, Corporate Business Development2008 — 2015
- Aadi Bioscience, IncBoard Observer2017 — 2021
- QuantuMDx Group LimitedBoard Member2020
- Gain TherapeuticsBoard Member2019 — 2020
- Amal TherapeuticsBoard Member2018 — 2019
- Thorne ResearchMember of the Integrative Care Division Operating Committee2011 — 2015
- IndenaDeputy Director, Business Development and Agreements2007 — 2008
- Nerviano Medical SciencesVice President, Pharmaceutical Sciences2004 — 2006
- Pfizer PharmaceuticalsSenior Director, Pharmaceutical Sciences - Nerviano Site Interim Manager2003 — 2004
- Pfizer PharmaceuticalsSenior Director, Pharmaceutical Sciences - R&D Italy Site Lead2001 — 2004
- Pfizer PharmaceuticalsSenior Director, Pharmaceutical Sciences1999 — 2001
- Pfizer PharmaceuticalsHead of New Drug Delivery Systems1988 — 1999
- Boehringer MannheimHead of Analysis Development Dept.1987 — 1988
- Farmitalia Carlo ErbaResearcher, Pharmaceutical R&D1983 — 1986
Skills & more
Drug Delivery54R&D53Technology Transfer37Drug Development38Pharmaceutical Sciences19Pharmacology19Lifesciences15Clinical Development23GLP12Biotechnology35Business Development11Oncology19
+12 more
PharmaceuticsRegulatory AffairsBiopharmaceuticalsPharmacovigilanceValidationProduct DevelopmentBusiness StrategyVaccinesPharmaceutical IndustrySopMarket AccessPharmaceutical SalesFrom Roberto's professional profile.
Deals · 2
OncoResponseBoard seat
via 3B Future Health Fund · filed May 2025
FORE US BioBoard seat
via 3B Future Health Fund · filed Aug 2023 · $122.6M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at 3B Future Health Fund
Alessandro Santoboni
Managing Director and General Partner at 3B Future Health Fund
Carlos von Bonhorst
Strategic Advisor at 3B Future Health Fund
Fabio Mastrosimone
Investor at 3B Future Health Fund
Francesco Giavatto
Chief Financial Officer and General Partner at 3B Future Health Fund
Francesco Granata
Strategic Advisor and General Partner at 3B Future Health Fund
Karin Hehenberger
Strategic Advisor at 3B Future Health Fund
Marianne Bjordal
General Partner at 3B Future Health Fund
Marianne Bjørdal
Partner at 3B Future Health Fund
Network2
Fabio Mastrosimone
Investor at 3B Future Health Fund
Francesco Granata
Strategic Advisor and General Partner at 3B Future Health Fund
Investors connected to Roberto in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Roberto De Ponti?
- Senior Advisor and pharmacist / EU Qualified Person with deep experience in pharmaceutical development, corporate ventures and strategic investments in oncology and rare diseases.
- Where does Roberto De Ponti work?
- Roberto De Ponti is Managing Director at 3B Future Health Fund and Board director at FORE US Bio and Board director at OncoResponse.
- What boards does Roberto De Ponti sit on?
- Roberto De Ponti holds tracked board seats at FORE US Bio, OncoResponse, OncoResponse.
Shared employers
Also worked at iOnctura5
Also worked at Thorne Research1
Also worked at Pfizer Pharmaceuticals189
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesSamar JahanVice President of Finance at Mission Biocapital
+ 183 more